22/12/2025
announces a significant investment of USD 72 million from hashtag Alternates.!
This strategic investment will enable us to further bolster our medical device manufacturing and in vitro diagnostics capabilities in India, driving innovation and excellence in healthcare technology. We are committed to delivering cutting-edge solutions that make a meaningful impact on patient care and outcomes.
A big thank you to the entire for their dedication and hard work. We are excited to continue our journey of growth and innovation in the healthcare sector!
Gratitude to Alternates for trusting Sensa Core's vision. Your investment of USD 72 million fuels our mission to innovate healthcare technology. Thank you for the confidence on Sensa Core"
We thank (“ ”) who acted as the exclusive financial advisor for our Sensa Core Company and delivering end-to-end transaction advisory – from investor identification and strategic deal structuring to diligence support, negotiations, and finalization of key commercial terms – culminating in the successful closure of the transaction.
https://www.entrepreneur.com/en-in/news-and-trends/motilal-oswal-alternates-invests-usd-72-mn-in-medical/501159
https://www.moneycontrol.com/news/business/motilal-oswal-pumps-72-million-into-hyderabad-based-medtech-sensa-core-13737119.html
https://smestreet.in/sectors/motilal-oswal-alternates-backs-medical-device-maker-sensa-core-10930492
We thank officials Dr. Ravi Kumar Meruva ,Founder, CEO & Chairman of Sensa Core Medical Instrumentation Pvt. Ltd., Mr Rohit Mantri, Managing Director and Co-Head of Motilal Oswal Financial Services Ltd., Abinandan T.S. & VP Rajan, Managing Directors of Veda Corporate Advisors, AiMed, and Association of Diagnostics Manufacturers of India (ADMI)
Motilal Oswal Alternates Invests USD 72 Million In Sensa Core To Support Medical Device Manufacturing And In Vitro Diagnostics In India. Finance | Sectors
